CAS RN: 565-53-7
Ethyl Dibromofluoroacetate
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250503
5g / 25g / 100g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 565-53-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥97%
0
Out of Stock
Beijing
Inquiry
565-53-7 / ethyl 2,2-dibromo-2-fluoroacetate
Standard CAS: 565-53-7
Multi CAS: Yes
Basic Information
copy
CAS
565-53-7 copy
Multi CAS
Yes copy
Molecular Formula
C4H5BR2FO2 copy
Molecular Weight
263.890000 copy
Exact Mass
263.861980 copy
InChI
InChI=1S/C4H5Br2FO2/c1-2-9-3(8)4(5,6)7/h2H2,1H3 copy
InChIKey
COYRDMUQLSIAEX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
0.75 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
Molar refractivity
38.33 copy
TPSA
26.3 copy
LogP / Solubility
WLOGP
1.96 copy
MLOGP
1.73 copy
XLogP3
2 copy
Consensus LogP
1.9 copy
Log S (ESOL)
-2.58 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.14 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.24 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.94 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy